Bevacizumab + Nivolumab + Rucaparib

Phase 2Active

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Peritoneal Cancer

Conditions

Peritoneal Cancer, Ovarian Cancer, Fallopian Tube Cancer

Trial Timeline

Nov 10, 2016 → Jan 1, 2027

NCT ID

NCT02873962

About Bevacizumab + Nivolumab + Rucaparib

Bevacizumab + Nivolumab + Rucaparib is a phase 2 stage product being developed by Bristol Myers Squibb for Peritoneal Cancer. The current trial status is active. This product is registered under clinical trial identifier NCT02873962. Target conditions include Peritoneal Cancer, Ovarian Cancer, Fallopian Tube Cancer.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02873962	Phase 2	Active	Nov 10, 2016	Jan 1, 2027	Peritoneal Cancer

Competing Products

20 competing products in Peritoneal Cancer

See all competitors

Product	Company	Stage	Hype Score
azenosertib	Zentalis Pharmaceuticals	Phase 2	44
MCY-M11 + Cyclophosphamide	MaxCyte	Phase 1	25
R744 + R744	Chugai Pharmaceutical	Phase 3	77
roxadustat	Astellas Pharma	Phase 3	77
Abemaciclib	Eli Lilly	Phase 1	33
M200 (Volociximab) + Liposomal Doxorubicin + M200 (Volociximab) + M200 (Volociximab)	AbbVie	Phase 1/2	41
Adavosertib + Paclitaxel + Carboplatin + Gemcitabine + PLD	AstraZeneca	Phase 2	52
Tremelimumab + Olaparib	AstraZeneca	Phase 1	33
ertapenem	Merck	Approved	85
Octreotide LAR + Octreotide (Immediate release) + methylprednisolone + Placebo	Novartis	Phase 2	52
PA21	Kissei Pharmaceutical	Phase 3	76
PF-06873600 + Endocrine Therapy 1 + Endocrine Therapy 2	Pfizer	Phase 1/2	40
Iniparib	Sanofi	Phase 2	51
Sevelamer Hydrochloride (Renagel®) + Calcium acetate (PhosLo® )	Sanofi	Phase 3	76
nanoliposomal irinotecan	Ipsen	Phase 1	30
Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution	Baxter	Approved	82
Anti-Adhesion Product	Baxter	Phase 2	49
Pioglitazone	Baxter	Pre-clinical	20
Icodextrin Peritoneal Dialysis Solution + Hypertonic Dextrose solution	Baxter	Approved	82
Radspherin	Oncoinvent	Phase 2	44

Other Products from Bristol Myers Squibb

DeucravacitinibApproved

Aripiprazole + Olanzapine + HaloperidolApproved

Irbesartan + CiprofibrateApproved

Entecavir + Lamivudine Placebo + Lamivudine + Entecavir PlaceboApproved

deucravacitinibApproved